Pfizer Inc. (LON:0Q1N)
London flag London · Delayed Price · Currency is GBP · Price in USD
26.62
-0.12 (-0.45%)
At close: Feb 20, 2026

Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of GBP 112.31 billion. The enterprise value is 147.33 billion.

Market Cap 112.31B
Enterprise Value 147.33B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date Feb 3, 2026
Ex-Dividend Date Jan 23, 2026

Share Statistics

Current Share Class 5.69B
Shares Outstanding n/a
Shares Change (YoY) +0.23%
Shares Change (QoQ) -0.49%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 66.55%
Float 5.68B

Valuation Ratios

The trailing PE ratio is 19.45 and the forward PE ratio is 8.96.

PE Ratio 19.45
Forward PE 8.96
PS Ratio 2.42
PB Ratio 1.62
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 25.52
EV / Sales 3.18
EV / EBITDA 7.74
EV / EBIT 10.37
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.67
Debt / EBITDA 2.41
Debt / FCF n/a
Interest Coverage 7.17

Financial Efficiency

Return on equity (ROE) is 8.58% and return on invested capital (ROIC) is 13.68%.

Return on Equity (ROE) 8.58%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 13.68%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 5.73%
Revenue Per Employee 574,027
Profits Per Employee 71,282
Employee Count 81,000
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax -197.64M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +3.38% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y) 0.44
52-Week Price Change +3.38%
50-Day Moving Average 25.96
200-Day Moving Average 24.92
Relative Strength Index (RSI) 50.09
Average Volume (20 Days) 129,699

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.95

Income Statement

In the last 12 months, Pfizer had revenue of GBP 46.50 billion and earned 5.77 billion in profits. Earnings per share was 1.01.

Revenue 46.50B
Gross Profit 35.25B
Operating Income 14.24B
Pretax Income 5.59B
Net Income 5.77B
EBITDA 19.09B
EBIT 14.24B
Earnings Per Share (EPS) 1.01
Full Income Statement

Balance Sheet

The company has 11.13 billion in cash and 46.02 billion in debt, with a net cash position of -34.89 billion.

Cash & Cash Equivalents 11.13B
Total Debt 46.02B
Net Cash -34.89B
Net Cash Per Share n/a
Equity (Book Value) 69.17B
Book Value Per Share 12.13
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin 75.81%
Operating Margin 30.62%
Pretax Margin 12.02%
Profit Margin 12.42%
EBITDA Margin 41.05%
EBIT Margin 30.62%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 1.29, which amounts to a dividend yield of 4.83%.

Dividend Per Share 1.29
Dividend Yield 4.83%
Dividend Growth (YoY) -3.37%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.23%
Shareholder Yield 4.61%
Earnings Yield 5.14%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 1, 1999. It was a forward split with a ratio of 3.

Last Split Date Jul 1, 1999
Split Type Forward
Split Ratio 3

Scores

Altman Z-Score n/a
Piotroski F-Score 2